News

QuickChek – September 23, 2021

Markets
0 min read



Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid Tumors

Ayala Pharmaceuticals announced the publication of two case studies of adult patients with desmoid tumors treated with AL101

Research, News & Market Data on Ayala

Watch recent presentation from Ayala



CanAlaska Deals Three Uranium Projects in the Athabasca Basin

CanAlaska Uranium announced it has entered into a Letter of Intent with Terra Uranium Pty Ltd, an Australian private limited corporation

Research, News & Market Data on CanAlaska

Watch recent presentation from CanAlaska



CoreCivic Announces Upsizing and Pricing of Tack-On Offering of $225 Million 8.25% Senior Notes Due 2026

CoreCivic announced that it successfully upsized and priced its offering

See today’s research report from Joe Gomes, Senior Research Analyst at Noble Capital Markets

Research, News & Market Data on CoreCivic

Watch recent presentation from CoreCivic



Gevo Acquires Butamax Patent Estate

Gevo announced that it has entered into an asset purchase agreement with Butamax Advanced Biofuels and its affiliate, Danisco US to acquire certain patents

Research, News & Market Data on Gevo

Watch recent presentation from Gevo



Capstone Green Energy (NASDAQ:CGRN) Receives Two Orders for Innovative Carbon-Neutral Renewable Energy Systems

Capstone Green Energy announced that it has received two orders for externally fired microturbines through its global energy conversion partner, Professor Dr. Berg & Kießling GmbH

Research, News & Market Data on Capstone Green Energy

Watch recent presentation from Capstone Green Energy

 

Stay up to date. Follow us:

 
Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.